Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 6:13 PM View:  | Fust Matthew K Director | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 138% 109.0K to 259.0K | |
| 02-Apr-24 6:11 PM View: | Mallik Ameet Director | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 194% 77.5K to 227.5K | |
| 02-Apr-24 6:12 PM View: | Roncarolo Maria Grazia Director | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 169% 88.5K to 238.5K | |
| 02-Apr-24 6:12 PM View: | Gallagher Carol Giltner Director | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 31% 479.61K to 629.61K | |
| 02-Apr-24 6:12 PM View: | Heiden William K Director | Atara Biotherapeutics, Inc. (ATRA) | 31-Mar-24 | Grant | 150,000 | -- | -- | 72% 209.0K to 359.0K | |
| 06-Mar-24 10:00 PM View: | Murugan Amar EVP, Chief Legal Officer | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 10,044 | $0.72 | $7,231.68 | (1%) 737.57K to 727.52K | |
| 06-Mar-24 10:00 PM View: | Nguyen Anhco EVP, Chief Sci. & Tech Officer | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 10,746 | $0.72 | $7,737.12 | (1%) 952.14K to 941.4K | |
| 06-Mar-24 10:00 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 24,844 | $0.72 | $17,887.70 | (1%) 1.94M to 1.91M | |
| 06-Mar-24 10:00 PM View: | Henrich Jill EVP, Global Head RA & Quality | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 3,879 | $0.72 | $2,792.88 | (< 1%) 558.88K to 555.0K | |
| 06-Mar-24 10:00 PM View: | Hyllengren Eric J EVP, CFO | Atara Biotherapeutics, Inc. (ATRA) | 04-Mar-24 | Sale | 6,679 | $0.72 | $4,810.34 | (< 1%) 681.0K to 674.32K | |
| 09-Jan-24 4:40 PM View: | Hyllengren Eric J EVP, CFO | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 475,000 | -- | -- | 231% 206.0K to 681.0K | |
| 09-Jan-24 4:40 PM View: | Murugan Amar EVP, Chief Legal Officer | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 475,000 | -- | -- | 181% 262.56K to 737.57K | |
| 09-Jan-24 4:40 PM View: | Nguyen Anhco EVP, Chief Sci. & Tech Officer | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 675,000 | -- | -- | 244% 277.14K to 952.14K | |
| 09-Jan-24 4:41 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 1,280,000 | -- | -- | 195% 655.5K to 1.94M | |
| 09-Jan-24 4:40 PM View: | Henrich Jill EVP, Global Head RA & Quality | Atara Biotherapeutics, Inc. (ATRA) | 08-Jan-24 | Grant | 450,000 | -- | -- | 413% 108.88K to 558.88K | |
| 20-Nov-23 10:00 PM View: | Henrich Jill EVP, Global Head RA & Quality | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-23 | Sale | 3,267 | $0.39 | $1,270.86 | (3%) 107.69K to 104.42K | |
| 20-Nov-23 10:00 PM View: | Joshi Manher EVP, Chief Medical Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-23 | Sale | 12,287 | $0.39 | $4,779.64 | (7%) 183.57K to 171.28K | |
| 20-Nov-23 10:00 PM View: | Hyllengren Eric J SVP, CFO | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-23 | Sale | 11,958 | $0.39 | $4,651.66 | (5%) 217.96K to 206.0K | |
| 15-Nov-23 5:07 PM View: | Gallagher Carol Giltner Director | Atara Biotherapeutics, Inc. (ATRA) | 14-Nov-23 | Purchase | 90,980 | $0.31 | $28,185.60 | 25% 368.44K to 459.42K | |
| 15-Nov-23 5:07 PM View: | Gallagher Carol Giltner Director | Atara Biotherapeutics, Inc. (ATRA) | 13-Nov-23 | Private Purchase | 179,020 | $0.22 | $40,028.90 | 95% 189.42K to 368.44K | |
| 14-Nov-23 6:29 PM View: | Heiden William K Director | Atara Biotherapeutics, Inc. (ATRA) | 10-Nov-23 | Private Purchase | 100,000 | $0.25 | $25,330.00 | 92% 109.0K to 209.0K | |
| 14-Nov-23 6:27 PM View: | Dobmeier Eric Director | Atara Biotherapeutics, Inc. (ATRA) | 10-Nov-23 | Private Purchase | 446,825 | $0.23 | $101,340.00 | 384% 116.5K to 563.33K | |
| 18-Aug-23 6:25 PM View: | Hyllengren Eric J SVP, CFO | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 8,186 | $1.65 | $13,526.80 | (4%) 226.14K to 217.96K | |
| 18-Aug-23 6:25 PM View: | Murugan Amar EVP, Chief Legal Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 8,672 | $1.65 | $14,329.80 | (3%) 274.06K to 265.39K | |
| 18-Aug-23 6:25 PM View: | Nguyen Anhco EVP, Chief Sci. & Tech Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 15,126 | $1.65 | $24,997.40 | (5%) 301.13K to 286.0K | |
| 18-Aug-23 6:25 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 30,766 | $1.65 | $50,834.80 | (4%) 706.67K to 675.9K | |
| 18-Aug-23 6:25 PM View: | Henrich Jill EVP, Global Head RA & Quality | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 3,346 | $1.65 | $5,531.50 | (3%) 111.04K to 107.69K | |
| 18-Aug-23 6:25 PM View: | Joshi Manher EVP, Chief Medical Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-23 | Sale | 6,975 | $1.65 | $11,526.50 | (4%) 190.55K to 183.57K | |
| 29-Jun-23 4:15 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-23 | Sale | 14,291 | $1.66 | $23,723.10 | (2%) 720.96K to 706.67K | |
| 02-Jun-23 8:06 PM View: | Seidenberg Beth C Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 3% 1.94M to 1.99M | |
| 02-Jun-23 7:09 PM View: | Gallagher Carol Giltner Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 43% 132.42K to 189.42K | |
| 02-Jun-23 7:09 PM View: | Dobmeier Eric Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 96% 59.5K to 116.5K | |
| 02-Jun-23 7:09 PM View: | Fust Matthew K Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 110% 52.0K to 109.0K | |
| 02-Jun-23 7:09 PM View: | Mallik Ameet Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 278% 20.5K to 77.5K | |
| 02-Jun-23 7:09 PM View: | Roncarolo Maria Grazia Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 181% 31.5K to 88.5K | |
| 02-Jun-23 7:08 PM View: | Heiden William K Director | Atara Biotherapeutics, Inc. (ATRA) | 31-May-23 | Grant | 57,000 | -- | -- | 110% 52.0K to 109.0K | |
| 18-May-23 8:17 PM View: | Hyllengren Eric J SVP, CFO | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 7,918 | $2.04 | $16,130.70 | (3%) 234.06K to 226.14K | |
| 18-May-23 8:17 PM View: | Murugan Amar EVP, Chief Legal Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 8,389 | $2.04 | $17,089.40 | (3%) 279.33K to 270.94K | |
| 18-May-23 8:17 PM View: | Banard Charlene A. EVP, Chief Technical Officer | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 19,040 | $2.04 | $38,784.50 | (6%) 295.05K to 276.01K | |
| 18-May-23 8:17 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 16-May-23 | Sale | 29,766 | $2.04 | $60,633.30 | (4%) 750.73K to 720.96K | |
| 06-Mar-23 6:46 PM View: | Dupont Jakob EVP, Head of R&D | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 5,074 | $3.63 | $18,403.40 | (2%) 295.87K to 290.79K | |
| 06-Mar-23 6:48 PM View: | Murugan Amar SVP, GC & Secretary | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 4,221 | $3.63 | $15,309.60 | (1%) 283.56K to 279.33K | |
| 06-Mar-23 6:49 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 15,679 | $3.63 | $56,867.70 | (2%) 766.41K to 750.73K | |
| 06-Mar-23 6:47 PM View: | Koppikar Utpal Chief Financial Officer | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 6,871 | $3.63 | $24,921.10 | (4%) 188.85K to 181.98K | |
| 03-Mar-23 5:16 PM View: | Banard Charlene A. EVP, Chief Technical Officer | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 139,700 | -- | -- | 90% 155.35K to 295.05K | |
| 03-Mar-23 5:15 PM View: | Dupont Jakob EVP, Head of R&D | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 141,328 | -- | -- | 91% 154.54K to 295.87K | |
| 03-Mar-23 5:15 PM View: | Murugan Amar SVP, GC & Secretary | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 155,375 | -- | -- | 121% 128.18K to 283.56K | |
| 03-Mar-23 5:16 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 324,711 | -- | -- | 74% 441.7K to 766.41K | |
| 09-Feb-23 5:00 PM View: | Koppikar Utpal Chief Financial Officer | Atara Biotherapeutics, Inc. (ATRA) | 07-Feb-23 | Sale (Planned) | 2,485 | $5.46 | $13,568.10 | (1%) 191.33K to 188.85K | |
| 18-Nov-22 8:13 PM View: | Touchon Pascal President and CEO Director | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-22 | Sale (Planned) | 15,591 | $4.49 | $70,003.60 | (3%) 457.29K to 441.7K |
